Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

CNS 6Lymphoid 3Endocrine 2Breast 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Plasma cell 1NET 1Genitourinary 1Gastrointestinal 1

Conditions

Neurotoxicity Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Hodgkin Disease 1Cytokine Release Syndrome 1

Interventions

Rituximab 1371Cyclophosphamide 1297Vincristine 662Doxorubicin 583Etoposide 525Prednisone 505Cytarabine 481fludarabine 462Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neuropsychological Tests × Lymphoid × Clear all
NCT05416554 2025-02-11

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

Stanford University

Phase NA Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT05510596 2024-08-09

MR-ICANS

University Hospital, Montpellier

Phase NA Completed
25 enrolled
Lymphoid

Cytokine Release Syndrome, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting
63 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡